Super thrilled to share my PhD thesis work, now out in @ScienceMagazine, revealing an unexpected redox checkpoint during endosomal progression via oxidative control of the ancestral PI 3-Kinase VPS34
https://t.co/y6Rhjw89M6
Our latest study out in @MolecularCell explores how and why MHC class I is aberrantly targeted for degradation via the autophagy-lysosome pathway in pancreatic cancer. Congrats to postdoc extraordinaire @marineberquez for leading this study! @UCSFAnatomy@UCSFCancer
COMMENT | JO Lundberg & MO Bergo (Karolinska Institute, SE)
This Comment explores how early mechanistic hypotheses can become entrenched #dietary#dogmas, affecting #research, policy, and public understanding
https://t.co/JEQps3XNgn
Detecting lung cancer 5 years before it happens, in @CellCellPress courtesy of the @CharlesSwanton group.
Astonishing translational work !
https://t.co/EvUmIGVLgs
Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer https://t.co/ck15pRBkSc
As a non-oncologist, i feel quite comfortable jumping on the bandwagon here. I can count the number of times I've seen unsolvable problems in medicine get solved in my lifetime. No, this is not a cure, but there has been no greater challenge than pancreatic cancer. Nothing worked. Now this...
These results are simply spectacular
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer | New England Journal of Medicine https://t.co/a52WwDQ2Ju
Exciting new work from @RobertoZoncu, led by all star first authors @clairegoul and @aakritijain24 reveals the mechanism mediating the sensing of lysosomal damage and recruitment of ESCRT for membrane repair. Beautiful work!🤩
https://t.co/fpazvFMciI